Xcelerate,
Inc. Announces
Investment
Banking Agreements
for Consulting
Services and
Acquisition
Financing.
Mauldin,
SC
-- June 10, 2021 -- InvestorsHub NewsWire
-- Xcelerate,
Inc. (OTC: XCRT) announced today it
has signed
two investment
banking agreements
with a leading New
York-based investment banking firm to assist in sourcing
capital.
(The
investment banking firm was founded in the late
1980's,
is one of the oldest in the United States, a full-service
broker-dealer employing over 300
people. The firm
manages
funds
with
over $2.8
Billion of retail accounts, nearly 100 registered representatives
and 50
investment advisors
in ten
offices).
Under
this
agreement,
the
Company has retained the
investment banking firm as its
exclusive placement
agent and financial advisor in connection with
acquisition
financing. The Company must
meet various terms and conditions which it believes are
reasonable and
attainable.
The Company's
chairman
and
chief executive officer,
Michael O'Shea,
said, "We are exceedingly
pleased
to
establish this
relationship with such a prestigious
firm,
which validates our business plan. We expect the assistance
of this
well-established
investment banker will accelerate our growth.
We have
launched an aggressive acquisition program
and have
begun
due diligence on several acquisition
targets.
Our management believes we can satisfy the conditions
in
our
investment banking
agreement"
ABOUT THE
COMPANY
"Xcelerate
has assembled an internationally recognized team of translational
clinicians and engineers to identify and acquire engineering
advancements and intellectual property that does not have
immediately obvious applications to medical technology and clinical
care. Xcelerate acquires innovation at the engineering / patent
level, marries it with appropriate early-stage operational med tech
companies and applies it in a controlled clinical care setting
which fosters engineering/clinical/business advancements under one
umbrella."
SAFE HARBOR AND
INFORMATIONAL STATEMENT
This press release
may contain forward-looking information within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended (the
Exchange Act), including all statements that are not statements of
historical fact regarding the intent, belief or current
expectations of the company, its directors or its officers with
respect to, among other things: (i)
the company's financing plans; (ii) trends affecting the company's
financial condition or results of operations; (iii) the company's
growth strategy and operating strategy; and (iv) the declaration
and payment of dividends. The words "may," "would," "will,"
"expect," "estimate," "anticipate," "believe," "intend" and similar
expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, many of which are beyond the
company's ability to control, and that actual results may differ
materially from those projected in the forward-looking
statements as a result
of various factors
including the risk disclosed in the company's registration
statement and reports filed with the SEC. The Company claims
the safe harbor provided by Section 21E(c) of the Exchange Act for
all forward-looking statements
Contact
-
For
more information about Xcelerate,
Inc.,
check
its EDGAR filings at:
http://www.sec.gov/ or
by calling Justin
Baronoff 561-750-9800;
justin@transmediagroup.com.
SOURCE
Xcelerate,
Inc.
(OTC: XCRT)
